© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
The Cooper Companies, Inc. (COO) stock declined over -0.02%, trading at $61.11 on NASDAQ, down from the previous close of $61.12. The stock opened at $61.59, fluctuating between $60.80 and $61.81 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 07, 2026 | 61.62 | 61.81 | 60.80 | 61.11 | 2.09M |
| May 06, 2026 | 61.50 | 61.71 | 60.00 | 61.12 | 3.28M |
| May 05, 2026 | 61.52 | 61.93 | 60.71 | 61.25 | 2.94M |
| May 04, 2026 | 61.95 | 62.87 | 61.24 | 61.52 | 1.57M |
| Apr 30, 2026 | 61.53 | 63.40 | 61.25 | 62.90 | 3.07M |
| Apr 29, 2026 | 62.79 | 63.44 | 60.64 | 61.34 | 2.4M |
| Apr 28, 2026 | 64.73 | 64.90 | 62.93 | 63.09 | 2.45M |
| Apr 27, 2026 | 64.44 | 65.29 | 64.20 | 64.34 | 2.06M |
| Apr 23, 2026 | 66.93 | 67.16 | 64.40 | 64.95 | 2.58M |
| Apr 22, 2026 | 67.46 | 68.02 | 66.85 | 66.92 | 2.22M |
| Apr 21, 2026 | 69.89 | 69.89 | 67.09 | 67.30 | 1.68M |
| Apr 20, 2026 | 69.45 | 70.30 | 69.28 | 69.46 | 1.38M |
| Apr 17, 2026 | 70.32 | 71.30 | 69.83 | 70.06 | 2.65M |
| Apr 16, 2026 | 70.34 | 70.97 | 69.29 | 69.38 | 2.14M |
| Apr 14, 2026 | 71.87 | 72.63 | 71.25 | 71.61 | 1.67M |
| Apr 13, 2026 | 70.74 | 71.80 | 69.83 | 71.70 | 1.44M |
| Apr 10, 2026 | 71.96 | 72.13 | 71.05 | 71.21 | 1.47M |
| Apr 09, 2026 | 71.14 | 71.85 | 70.08 | 71.46 | 1.28M |
| Apr 08, 2026 | 72.20 | 72.23 | 71.11 | 71.73 | 2.24M |
| Apr 07, 2026 | 70.10 | 70.30 | 68.70 | 69.66 | 2.18M |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
| Employees | 16000 |
| Beta | 1.07 |
| Sales or Revenue | $4.09B |
| 5Y Sales Change% | -0.587% |
| Fiscal Year Ends | October |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |